Teva Pharmaceutical (TEVA) was downgraded today by Morgan Stanley (MS) from overweight to equal-weight with a price target of $47, as the firm believes that the stock has gotten ahead of itself recent. Thomson Reuters (TRI) today had its numbers reduced by Credit Suisse (CS) due to challenges in the financial sector.
